A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
Susan T. Iannaccone, Zohair Nanjiani
Jonathan S. Katz, David S. Saperstein
John Newsom-Davis
Deborah F. Gelanis
Anthony A. Amato, Richard J. Barohn
Matthew P. Wicklund, John T. Kissel
JD Bartleson
Rigmor Jensen
William B. Young
Elizabeth Loder
scroll for more
use your arrow keys for more
scroll or use arrow keys for more